<?xml version="1.0" encoding="UTF-8"?>
<p id="p0085">Hydroxychloroquine and chloroquine have demonstrated 
 <italic>in vitro</italic> antiviral effectiveness against Herpes simplex virus type 1 [
 <xref rid="bb0040" ref-type="bibr">8</xref>], Zika [
 <xref rid="bb0045" ref-type="bibr">9</xref>,
 <xref rid="bb0050" ref-type="bibr">10</xref>], HIV [
 <xref rid="bb0055" ref-type="bibr">11</xref>], MERS [
 <xref rid="bb0060" ref-type="bibr">12</xref>], SARS-CoV [
 <xref rid="bb0060" ref-type="bibr">12</xref>], HCoV-OC43 [
 <xref rid="bb0065" ref-type="bibr">13</xref>], Chikungunya [
 <xref rid="bb0070" ref-type="bibr">14</xref>], Hepatitis C [
 <xref rid="bb0075" ref-type="bibr">15</xref>], and several other viruses [
 <xref rid="bb0055" ref-type="bibr">11</xref>,
 <xref rid="bb0080" ref-type="bibr">16</xref>]. For coronavirus, some studies suggested, at least 
 <italic>in vitro</italic>, some efficacy of chloroquine on the SARS-CoV virus [
 <xref rid="bb0060" ref-type="bibr">12</xref>,
 <xref rid="bb0065" ref-type="bibr">13</xref>] or MERS-CoV [
 <xref rid="bb0085" ref-type="bibr">17</xref>].
</p>
